Please login to the form below

Not currently logged in

IPHA names Janssen's Dr Leisha Daly as president

Has been vice president since 2012

edit-Leisha-Daly-2014-104Janssen's country director for Ireland Dr Leisha Daly has been elected as president of the Irish Pharmaceutical Healthcare Association (IPHA).

The role will see Daly, who has served as the Irish pharma association's vice president since 2012, represent the research-based pharma industry in Ireland.

Commenting on her election, Daly said: “As the new IPHA president, I will endeavour to working partnership with all relevant groups to ensure that patients in Ireland have access to optimal healthcare solutions.

“I believe that continued dialogue with the HSE and the Department of Health is critical to achieve our common goal - the health of Irish patients. Our doors remain open for collaboration and partnership and I am looking forward to us continuing this work in the interest of Irish patients over the next two years.”

Daly, who has also been a member of IPHA's board of directors since June 2012, was reappointed to the Association's Prescription Medicines Division Strategy Board in August 2012.

She joined Janssen as head of technical affairs in 1998 and since then has served in a variety of senior positions in medical, sales and marketing. Daly is also a member of the Janssen UK board of directors.

7th October 2014

From: Regulatory



Featured jobs

Subscribe to our email news alerts


Add my company
Genetic Digital

We help healthcare, pharma & medical device organisations use web and mobile technologies to effectively connect patients and healthcare professionals....

Latest intelligence

How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...
figure 1
The valuable brand
Creating value beyond the pill is both possible and increasingly necessary...